Categories
Pharmaceutical

NGS Sample Preparation for Drug & Biomarker Discovery Poised to Reach Higher Echelons

The global NGS sample preparation market is expected to surpass a valuation of US$ 4 billion by 2031, expanding at a whopping CAGR of approximately 16% across the 2021-2031 forecast period, according to a recent report published on the market by award-winning consulting firm Fact.MR. Demand for NGS sample preparation kits, reagents & consumables is expected to embark on a positive trajectory. Next generation sequencing (NGS) has revolutionized genomic research, paving the way for highly effective diagnosis of numerous chronic and infectious diseases, a fact that is boding well for market growth.

Historically, the market accrued significant gains, surpassing US$ 750 million in value in 2019. In recent years, NGS has been widely deployed in clinical oncology to advance personalized cancer treatment. The technique has proven useful in identifying novel and rare cancer mutations, detecting familial cancer mutation carriers, and providing molecular rationale for appropriate targeted therapy.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=5932

Consequently, prominent manufacturers are introducing a slew of sample preparation products, with opportunities being ample across the Asian markets. For instance, in May 2021, BGI Group signed a MoU with Ethiopian Biotechnology Institute (EBiT) to conduct the HPV genotyping pilot project and complete 2,000 sample screenings from Ethiopia, to establish a new model of HPV screening, diagnosis, and treatment.

Key Takeaways from Market Study

  • High demand for NGS sample preparation kits, reagents, and consumables
  • By application, NGS sample preparation for drug & biomarker discovery poised to reach higher echelons
  • Academic and research institutes to remain primary NGS sample preparation end users
  • Presence of robust healthcare system to pivot NGS sample preparation product sales across the U.S.
  • India to extensively deploy NGS sample preparation products to augment prenatal screening

“Prominent NGS sample preparation product manufacturers are testing uncharted waters by foraying into domains such as animal and plant health, to develop highly advanced diagnostic approaches and address multiple ailments, widening expansion prospects,”  comments a Fact.MR analyst.

Get Customization on this Research Report for specific research solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=5932

Key Market Segments Covered

  • Product Type
    • NGS Sample Preparation Instruments
    • NGS Sample Preparation Kits, Reagents & Consumables
  • Application
    • NGS Sample Preparation for Drug & Biomarker Discovery
    • NGS Sample Preparation for Diagnostics
    • NGS Sample Preparation for Precision Medicines
    • Others
      • Agriculture
      • Animal Research
  • End User
    • Hospitals & Diagnostic Centers
    • Biotechnology & Pharmaceutical Companies
    • Academic & Research Institutes
    • Others
      • CROs
      • CMOs
  • Region
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of MEA

Full Access of this Report Is Available at https://www.factmr.com/checkout/5932

Competitive Landscape

The global NGS sample preparation market appears fragmented in nature, characterized by the presence of numerous regional and global level market players. Major expansion strategies include introducing testing kits equipped with the latest technology, collaboration with existing manufacturers, and acquisition of other players.

  • In April 2021, F. Hoffmann-La Roche’s subsidiary Geronimo Acquisition Corp. purchased shares of GenMark Diagnostics Inc. in a tender offering to further research in controlling antibiotic resistance and infectious diseases by broadening its in-class molecular diagnostics portfolio
  • In March 2021, Agilent Technologies completed and launched the CE-IVD registered qRT-PCR in vitro diagnostic kit for the detection of SARS-CoV-2 RNA, validated with a variety of commercially available RNA extraction products

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the NGS sample preparation market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (instruments, and kits, reagents, and consumables), application (drug & biomarker discovery, diagnostics, precision medicine, and others [agriculture and animal research]), and end user (hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutions,and others [CROs, CMOs, etc.]) across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

For More Insights https://www.biospace.com/article/cell-proliferation-market-players-are-relying-on-partnerships-and-alliance-to-speed-up-r-and-d-study/

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

NGS Sample Preparation Market is expected to be valued at over US$ 4 billion by 2031

The global NGS sample preparation market is expected to surpass a valuation of US$ 4 billion by 2031, expanding at a whopping CAGR of approximately 16% across the 2021-2031 forecast period, according to a recent report published on the market by award-winning consulting firm Fact.MR. Next generation sequencing (NGS) has revolutionized genomic research, paving the way for highly effective diagnosis of numerous chronic and infectious diseases, a fact that is boding well for market growth.

Historically, the market accrued significant gains, surpassing US$ 750 million in value in 2019. In recent years, NGS has been widely deployed in clinical oncology to advance personalized cancer treatment. The technique has proven useful in identifying novel and rare cancer mutations, detecting familial cancer mutation carriers, and providing molecular rationale for appropriate targeted therapy.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=5932

In recent years, NGS sample preparation market gained growth due to advancements in clinical oncology to offer effective cancer treatment. NGS sample preparation technique has proved effective approach in identifying novel and rare cancer mutations and in detecting familial cancer mutation carriers. Thus, increasing prevalence of the diseases will boost the demand for NGS sample preparation.

Key Takeaways from Market Study

  • High demand for NGS sample preparation kits, reagents, and consumables
  • By application, NGS sample preparation for drug & biomarker discovery poised to reach higher echelons
  • Academic and research institutes to remain primary NGS sample preparation end users
  • Presence of robust healthcare system to pivot NGS sample preparation product sales across the U.S.
  • India to extensively deploy NGS sample preparation products to augment prenatal screening
ngs sample preparation market
“Prominent NGS sample preparation product manufacturers are testing uncharted waters by foraying into domains such as animal and plant health, to develop highly advanced diagnostic approaches and address multiple ailments, widening expansion prospects,”

comments a Fact.MR analyst.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5932

Competitive landscape:

Key players in NGS Sample Preparation Market are adopting various strategies to increase their revenue share. For instance:

  • In April 2021, QIAGEN N.V introduced the QIAseq DIRECT SARS-CoV-2 Kit, a viral genome enrichment and library preparation solution to reduce library turnaround times and plastics use for NGS.
  • Thermo Fisher Scientific approved a definitive agreement to acquire PPD Inc. at a purchase price of US$ 17.4 billion to enhance innovation and development in drug productivity.
  • In May 2021, Integrated DNA Technologies (IDT) Inc. collaborated with Swift Biosciences to augment its NGS library preparation genomics kits for academic, translational and clinical research.

Other key players operating in market are Merck KGaA (Merck Millipore), F. Hoffmann-La Roche Ltd, Agilent Technologies, Promega Corporation, Illumina Inc, Integrated DNA Technologies Inc. (Danaher Corporation), New England Biolabs, and Tecan Trading AGing.

Get More Insights- https://www.biospace.com/article/ngs-sample-preparation-market-surging-at-16-percent-cagr-rising-demand-for-effective-treatment-of-chronic-diseases-driving-growth-fact-mr-study-/

More Insights on the Global NGS Sample Preparation Market:

Fact MR, in its new offering, brings to fore an unbiased analysis and global industry analysis of the global NGS sample preparation market, presenting historical demand data (2016-2020) and forecast statistics for the period (2021-2031). The study divulges compelling insights on the NGS sample preparation market with detailed segmentation based on product type (NGS sample preparation instruments, sample preparation kits, reagents, and consumables), based on application (NGS sample preparation for drug and  biomarker discovery, sample preparation for diagnostics sample preparation for precision medicines, and others as agriculture and animal research), based on end users (hospitals and  diagnostic centers, biotechnology, pharmaceutical , and academic and research institutes)

Explore Fact.MR’s Coverage on the Healthcare Domain

NGS Data Analysis Market: A new report of Fact.MR envisages the global market for NGS data analysis to record a spectacular growth during the forecast period (2017-2026).

Oncology Small Molecule Drugs Market: Fact.MR’s “Oncology Small Molecule Drugs Market – Global Market Insights 2019-2029,” provides a detailed analysis on the global oncology small molecule drugs market. Size of the oncology small molecule drugs market has been analyzed in a comprehensive way and is presented in terms of value (US$ Mn).

Glaucoma Diagnostics Market: The global Glaucoma Diagnostics market is anticipated to show significant growth as Optical Coherence Tomography (OCT) Imaging Systems, Corneal Pachymeters, Tonometers offers greater advantage over tradition procedures for diagnosis of glaucoma.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/ngs-sample-preparation-market
Press Release: https://www.factmr.com/media-release/1992/global-ngs-sample-preparation-market